• Careers
  • Events
  • Library
  • Global Reach
  • News
logo-small
  • Why Veristat
    • About Us
    • Our Approach
    • Our Leadership
    • Success Stories
    • News
    • Locations
    • Careers
      • Core Values
      • Explore Benefits
      • Grow Your Career
      • Because We Care
      • Why Veristat
  • Therapeutic Areas
    • Oncology
    • Infectious Disease
    • Endocrine/Metabolic
    • CNS/Neurology
    • Cardiovascular Disease
    • More Therapy Areas
  • Solutions
    • Full Service
      • Clinical Trial Planning
      • Clinical Trial Conduct
      • Regulatory Submission
    • Resourcing/FSP
    • Cell and Gene Therapies
    • Decentralized Trials
    • Rare Diseases
    • Rescue Trials
    • Vaccine Trials
  • Services
    • Strategic Consulting
      • Adaptive Designs
    • Regulatory Affairs
      • Regulatory Consulting
      • Marketing Applications
      • Agency Meetings
      • Regulatory Publishing
      • Medical Devices/IVDs
    • Clinical Operations
      • Project Management
      • Monitoring & Site Management
      • Patient Recruitment
      • Patient Retention & Site Engagement
    • Medical Affairs
      • Clinical Trial Safety
      • Data Review Committees
      • Medical Monitoring
    • Medical Writing
    • Biometrics
      • Data Management
      • Biostatistics
      • Statistical Programming
      • Standards Implementation
    • Pharmacovigilance
  • Knowledge Base
    • Library
    • Blog
    • Webinars
    • Success Stories
    • Newsletter
  • Contact Us
  • RFP

Articles/Whitepapers & Insight Briefs

Resources

Successful Preparation Strategies for NDA/MAA Marketing Applications

Essential Considerations for Adaptive Design in Clinical Trials

Interpreting The Regulatory Perspective on Adpative Designs

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer

Adaptive Designs- Recent Advancement in Clinical Trials

Systemic Comparison of the Statistical Operating Characteristics of Various Phase I Oncology Designs

Biomarker Driven Adaptive Design for Precision Medicine

Competing Risk Analysis in A Large Cardiovascular Clinical Trial

Pooled Analysis of the Phase 3 REVIVAL Trials

Contact Us
Request A Proposal

Get Updates

  • Why Veristat
    • About Us
    • Our Approach
    • Our Leadership
    • Success Stories
    • News
    • Careers
      • Open Positions
      • Core Values
      • Explore Benefits
      • Grow Your Career
      • Because We Care
      • Why Veristat
  • Therapeutic Areas
    • Oncology
    • Infectious Disease
    • Endocrine/Metabolic
    • CNS/Neurology
    • Cardiovascular Disease
    • More Therapy Areas
  • Solutions
    • Full Service
    • Strategic Resourcing
    • Cell and Gene Therapies
    • Decentralized Trials
    • Rare Diseases
    • Rescue Trials
    • Vaccine Trials
  • Services
    • Strategic Consulting
      • Adaptive Designs
    • Regulatory Affairs
      • Regulatory Consulting
      • Regulatory Approvals
      • Agency Meetings
      • Regulatory Publishing
    • Chemistry, Manufacturing, and Controls (CMC)
    • Clinical Operations
      • Project Management
      • Monitoring & Site Management
      • Patient Recruitment
      • Patient Retention & Site Engagement
    • Medical Affairs
      • Data Review Committees
      • Medical Monitoring
      • Safety/Pharmacovigilance
    • Medical Writing
    • Biometrics
      • Data Management
      • Biostatistics
      • Statistical Programming
      • Standards Implementation
      • Pharmacovigilance
  • Privacy Policy

  • ©2023 Veristat, LLC. All rights reserved. Veristat is a trademark of Veristat, LLC. All other trademarks are the property of their respective owners.